Unknown

Dataset Information

Clinical efficacy, safety and tolerability of aliskiren monotherapy: a protocol for an umbrella review.


ABSTRACT:

Introduction

Aliskiren is a newly developed medicine. As one of the effective renin-angiotensin-aldosterone system inhibitors, its role in lowering blood pressure has been recognised. However, its safety and tolerability still remain controversial. The aim of the paper is to systematically summarise the published studies about the clinical efficacy and side effects of aliskiren monotherapy.

Methods and analysis

A comprehensive review of PubMed, Embase and Cochrane Library databases published from inception until June 2019 will be conducted. The selected articles are meta-analyses that integrated the randomised controlled studies, which evaluated efficacy, safety and tolerability of aliskiren monotherapy. Two people will select eligible articles and extract data independently

SUBMITTER: Zhao Q 

PROVIDER: S-EPMC7045264 | biostudies-literature | 2020 Jan

REPOSITORIES: biostudies-literature